FDA Report Details Issues At Novartis' Lincoln Plant

By: Associated Press Email
By: Associated Press Email

A new FDA report says Novartis was slow to address problems at its Lincoln, Neb., manufacturing plant.

The Jan. 20 inspection report may also shed light on why Novartis temporarily closed the plant in December and recalled several of its over-the-counter drugs last month, including Excedrin, NoDoz and Gas-X.

The FDA inspectors say six of the 10 problems they found in December were repeat offenses initially discovered last July. For
instance, the FDA says Novartis was overdue in responding to nearly
1,400 consumer complaints.

Some of the complaints sound similar to the reason for the recall because consumers had reported finding foreign tablets or objects in the product.

Novartis officials say the plant was shut down for maintenance, not because of the FDA inspection.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WOWT NBC Omaha 3501 Farnam Street Omaha, NE 68131 (402) 346-6666 sixonline@wowt.com
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 138480814 - wowt.com/a?a=138480814
Gray Television, Inc.